Communications leader helping the world understand biomedicine. Views here are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ryan McBride
Pennsylvania Commonwealth Court Refuses to Expand Exceptions to Political Subdivision Tort Claims Act
In the matter of Gabra v. Borough of Prospect Park, 2026 LX 302776 (Cmwlth. June 18, 2026), the Commonwealth Court reversed a Delaware County Court of Common Pleas Order which partially denied the Borough’s motion for summary judgment. The case involved a motor vehicle accident within a borough park where a driver struck the base of a water fountain and ran over and killed a family member who got out of the car to try to aid the driver in turning around.
PowerPoint Presentation Protected by Pennsylvania Peer Review Protection Act | JD Supra
Peer review litigation in Pennsylvania has been quiet since the Pennsylvania Supreme Court handed down the Leadbitter decision in 2021.[1] In Leadbitter, the Court held that regardless of label, a committee that conducts peer review enjoys the protections of the Pennsylvania Peer Review Protection Act (PRPA), and its proceedings and documents generated are privileged.
Roborock Q Revo Review
Introduced in late 2022 as an affordable, fully autonomous robot vacuum and mop combo, the Roborock Q Revo aims to simplify cleaning for users seeking the best vacuum cleaner performance possible with less manual effort. It comes with an auto-empty dock rated to carry up to 60 days’ worth of debris and promises easy bag replacement. The Q Revo has a 5500-Pa suction motor and dual spinning mop pads.
Roborock Q7 Max+ Review
Roborock S8+ Review True Score 64 94 85 84 Ranking Market Context The Roborock Q7 Max+ is a premium robot vacuum released in late 2022, with a self-emptying dock and sophisticated autonomous navigation. It uses LIDAR as… The Roborock Q7 Max+ is a premium robot vacuum released in late 2022, with a self-emptying dock and sophisticated autonomous navigation. It uses LIDAR as well as optical sensors and features smart mapping capability with virtual walls and no-go zones.
How To Fix Bent Pins For A SD Card In A Digital Camera
Learning how to fix bent pins for an SD card in a top-rated digital camera is a career-saving move in digital photography. If the card pins become bent, you won’t be able to get your photos. You should take any sign of physical damage seriously. Luckily, it isn’t too difficult to straighten them out yourself. After you do it a couple of times, you should be golden. KEY TAKEAWAYS: Straightening bent pins take very few supplies and the entire process should take a few minutes at most.
What Is ACEP Fighting for in 2023?
Every year, ACEP’s Federal Government Affairs Committee and the ACEP federal advocacy team work together to establish an expansive list of goals and priorities that guide ACEP’s work on Capitol Hill for the upcoming legislative session. When a new Congress convenes every two years, we reach out to every Member of Congress to share our top legislative priorities, which also form the basis for our in-person advocacy during the upcoming Leadership & Advocacy Conference.
Washington Court Of Appeals Issues Important Decision On Arbitration Agreements In Long Term Care Setting
United States: Washington Court Of Appeals Issues Important Decision On Arbitration Agreements In Long Term Care Setting 21 December 2021 by Ryan McBride and Carin Marney Lane Powell To print this article, all you need is to be registered or login on Mondaq.com.
Don’t Forget to Leave the Office Once You Return: 5 Places to Disconnect
As more and more of us are returning to work full-time in our physical offices, it is as important as ever to remember to physically and mentally take care of ourselves. Just over 70% of respondents to The American Lawyer’s 2021 Mental Health and Substance Abuse Survey stated that the COVID-19 pandemic made their mental health worse.
Ethics Forum: Questions and Answers on Professional Responsibility
I am an attorney who has received a suspension many, many years ago and was reinstated. I have had no problem since and have done well in my law practice. The first thing that comes up on the computer during a search of my name is the fact that I had discipline many years ago. Can that get expunged after a period of time? Samuel C. Stretton. The unfortunate answer is no. The only thing that ever gets expunged is an informal admonition after five years if there has been no other discipline.
2020's Impact: A Day of Reckoning for Law Firm Leaders?
A heartfelt thank you for the esteemed group of people with brilliant minds, creative ideas and generous hearts who joined an engaging conversation upon which this article is based: Tim Corcoran, Patrick Fuller, Heidi Gardner, Susan Manch, John “The Purple Coach” Mitchell, Kathleen Pearson and James Willer.
Siding With Cozen, Court Says Self-Defense Exception to Professional Conduct Rules Can Outweigh Privilege
In an apparent issue of first impression, the Pennsylvania Superior Court has ruled in a Dragonetti Act lawsuit against Cozen O’Connor that the state’s attorney conduct rules permit lawyers to disclose otherwise privileged documents into discovery in their own defense. A three-judge panel consisting of Judges Deborah Kunselman, Megan McCarthy King and Daniel Pellegrini held in the Montgomery County case of Perelman v.
Transitioning to Private Practice From an In-House or Government Position
What those of us who didn’t pay much attention to Latin class in grade school quickly learned upon entering law school is how indigenous Latin phraseology is to the legal profession. As it turns out, we couldn’t avoid learning some Latin after all we did not go to medical school.
Zooming—What Others See May Not Be What You Want Them to See | The Legal Intelligencer
The times they are a changing. The world has changed a lot since those days long ago, that is, before the pandemic began and lawyers discovered that they were no longer entering courtrooms and were instead appearing on Zoom, Webex and similar platforms. As a result of the sudden transition to a remote, videoconferencing format, lawyers have taken a lot for granted.
GC Impact 2021: David Battisti
Over the past year, as consumers and businesses alike relied more heavily than ever on transportation, logistics, warehousing and related services, Penske had to meet increasingly difficult challenges. Operating within the labyrinth of government orders, coupled with increased volumes and sophisticated attendance and safety policies and procedures, made meeting those challenges extremely difficult.
The Shifting Landscape and Proliferation of Books and Records Demands in Delaware
Section 220 of the General Corporation Law of the State of Delaware provides stockholders with the right to inspect the books and records of a corporation for a “proper purpose” that is “reasonably related to such person’s interest as a stockholder.” Delaware courts have long urged stockholders to utilize Section 220 investigations as one of the “tools on hand” prior to filing derivative lawsuits.
Law Firm Innovators 2021: Joann Needleman
Needleman, leader of Clark Hill’s consumer financial services regulatory & compliance group, is nationally recognized in the field of financial regulation and has worked closely with both industry and financial services regulators to develop common sense solutions to balance regulation and consumer protection.
Pennsylvania Superior Court Shifts Focus of Venue Analysis | JD Supra
With Hangey v. Husqvarna Prof'l Prods., 2021 PA Super 37, the Pennsylvania Superior Court handed down an en banc decision which will significantly shift the focus of how venue challenges are decided. When a corporate defendant is not a resident of a plaintiff’s chosen venue, and the incident giving rise to the lawsuit did not occur there, venue will only remain if the defendant “regularly conducts business” there.
Stanford’s Computer Models – Inventive for Parents, but Not for Patents | JD Supra
IN RE: BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY Before Prost, Lourie, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: The specific combination of purely mathematical steps in a claim are not inventive enough to transform patent ineligible mathematical algorithms and mental processes. Stanford University filed a patent for a computerized statistical model for determining Haplotype phases, which can help predict which parent gave a child a certain gene.
Comprehensive, Round Two: Virginia Passes the Second General Data Privacy Law | JD Supra
Virginia just became the second state to pass a comprehensive privacy law, the Consumer Data Protection Act (“CDPA”). Business and privacy professionals should evaluate the ramifications: what does it require, who does it apply to, and what are the penalties?
California Court Determines the CCPA Does Not Restrict Discovery in Civil Litigation | JD Supra
A recent legal decision held that privacy guarantees in the California Consumer Privacy Act (the “CCPA”) do not prevent discovery in civil litigation. In Will Kaupelis v. Harbor Freight Tools USA, Inc., the Central District of California concluded the CCPA does not limit the scope of discovery in civil litigation because it does not restrict the ability to comply with the Federal Rules of Civil Procedure. Case 8:19-cv-01203-JVS-DFM, Dkt, No. 158 (C.D. Cal Jan. 22, 2021).
No Simulating Alice Requirements: Application Of Abstract Ideas Alone Cannot Transform Patent Ineligible Subject Matter
United States: No Simulating Alice Requirements: Application Of Abstract Ideas Alone Cannot Transform Patent Ineligible Subject Matter 04 January 2021 by Kendall Loebbaka , Ryan W. McBride and Paul Stewart Knobbe Martens To print this article, all you need is to be registered or login on Mondaq.com. SIMIO, LLC V. FLEXSIM SOFTWARE PRODUCTS, INC. Before Prost, Clevenger, and Stoll. Appeal from the United States District Court for the District of Utah.
No Simulating Alice Requirements: Application of Abstract Ideas Alone Cannot Transform Patent Ineligible Subject Matter | JD Supra
SIMIO, LLC V. FLEXSIM SOFTWARE PRODUCTS, INC. Before Prost, Clevenger, and Stoll. Appeal from the United States District Court for the District of Utah. Summary: A claim whose only inventive concept is the applications of an abstract idea using conventional and well-understood techniques is not sufficient to transform the claim into a patent-eligible idea.
China, The World’s Largest Online Population, Introduces Its First Comprehensive Personal Information Protection Law | JD Supra
The People’s Republic of China (“China”) has introduced its first comprehensive data privacy law, which will explicitly protect the personal information of its residents. On October 21, 2020, China’s legislative body submitted a draft bill for the Personal Information Protection Law (“PIPL”) that would prohibit businesses and enterprises from misusing the personal information of Chinese residents.
California Genetic Information Privacy Act Vetoed | JD Supra
On September 25, 2020, Governor Gavin Newsom vetoed the California Genetic Information Privacy Act (“GIPA”), about which we reported here.
California Passes the Genetic Information Privacy Act | JD Supra
UPDATE: On September 25, 2020, Governor Gavin Newsom vetoed the California Genetic Information Privacy Act (“GIPA”). Click here for an update. On August 31, 2020, the California Legislature passed the Genetic Information Privacy Act (“GIPA”), which regulates the privacy and security aspects of Direct-to-Consumer (“DTC”) genetic testing and testing companies. If Governor Gavin Newsom signs GIPA into law, it will take effect on January 1, 2021.
The California Consumer Privacy Act Business-to-Business and Human Resources Data Limited Exemptions Extended One More Year | JD Supra
The California Legislature has delayed its plans to expand the scope of the California Consumer Privacy Act (“CCPA”) and make all of its provisions apply to personal information related to business-to-business communications and transactions and human resources data. When the CCPA went into effect on January 1, 2020, business-to-business and human resources data were subject to limited exemptions that were set to expire on December 31, 2020. A description of these exemptions can be found here.
Natural Law and Nothing More | JD Supra
AMERICAN AXLE & MANUFACTURING v. NEAPCO HOLDINGS LLC Before Dyk, Moore, and Taranto. Appeal from the District Court for the District of Delaware. Summary: Claims directed to a law of nature, without more, may not be patent eligible. American Axle & Manufacturing (“AAM”) sued Neapco Holding, LLC for patent infringement for AAM’s patents for improved prop shafts. Both parties filed cross motions for summary judgment on the patent eligibility of independent claims 1 and 22.
Facts in Complaint That Arguably Show Patent Ownership Are Sufficient to Confer Standing | JD Supra
SCHWENDIMANN V. ARKWRIGHT ADVANCED COATING, INC. Before Wallach, Reyna, and O’Malley. Appeal from the United States District Court for the District of Minnesota. Summary: Exclusionary rights in a patent are a prerequisite to obtaining relief for patent infringement, but need not be proven to establish constitutional standing and subject matter jurisdiction. Jodi Schwendimann sued Arkwright Advanced Coating for infringing 6 patents.
Inducing Delay: When a Court Can Deviate From the First-To-File Rule | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
Congress Backs Alternatives to Opioids (ALTO) in the ED Program
In December 2019, Congress authorized funding for the Alternatives to Opioids (ALTO) in the Emergency Department program—the final step in the legislative process needed to set the ALTO grant program in motion and another significant victory for ACEP’s federal advocacy efforts. Background The ALTO program was originally developed by ACEP President-Elect Mark Rosenberg, DO, MBA, FACEP, and Alexis LaPietra, DO, FACEP, and their team at St. Joseph’s University Medical Center in New Jersey in 2016.
Joseph Harrington, Author at ACEP Now
About Joseph Harrington This author hasn't entered any profile information yet. Don’t Overlook Traumatic Brain Injury in Intimate Partner Violence March 17, 2020 - Heather V. Rozzi, MD, FACEP; and Ralph Riviello, MD, MS, FACEP - 0 Comment The Case A 24-year-old woman is brought to the emergency department via EMS.
Curator wanted for historic Ipswich farmhouse
IPSWICH — In the years following World War II, Jim Tedford remembers his mother heating up a cast iron pan, wrapping it in newspaper and placing it at the foot of his bed. The old farmhouse he lived in for nearly four years was always cold, he said, “but it was home.” The Whitehead House, which sits on the northern edge of Willowdale State Forest in Ipswich, had its own chicken coop, barn and large elm tree outside its door.
Paid leave contributions from employers will rise amid delay
Employers have been granted a temporary reprieve from the state's new paid family and medical leave law, but it will end up costing them. Beacon Hill's top three leaders — Gov. Charlie Baker, Senate President Karen Spilka and House Speaker Robert DeLeo — have agreed to a three-month delay of the required contributions under the Paid Family and Medical Leave Act, "to ensure businesses have adequate time to implement" the program. The law had been set to go into effect July 1.
Athenahealth Paying Dearly to Take on Larger Rivals
Athenahealth is a high-flier in the Boston business community, led by the outspoken and forceful Jonathan Bush. Bush, however, openly admits that his Watertown, MA-based company (NASDAQ:ATHN) is relatively unknown outside of local business and technology circles—including among most U.S. physicians. Athena has been ramping up efforts to raise its profile among doctors, the target audience for its Internet-enabled billing and electronic health records services.
Forma and Novartis Form Cancer Drug Collaboration
Forma and Novartis Form Cancer Drug Collaboration Xconomy Boston — Forma Therapeutics, a Cambridge, MA-based biotech firm, said this morning that it has landed a drug-discovery collaboration with Swiss drug giant Novartis. Novartis, which has previously invested in Forma through its Novartis Option Fund, is tapping the biotech startup to apply its cell-based screening platform to discover inhibitor treatments that target protein-to-protein interactions in cancer.
Last-minute drive at FDA added 6 new drug approvals | FierceBiotech
The push to a record rate of new drug approvals required a big fourth-quarter effort on the part of the FDA. In December the agency handed out 8 new drug OKs, and six of them came in the waning days of 2012, after FierceBiotech had begun its official publishing break for the holidays. Our readers who regularly check our website know that we kept up with the news online. But for everyone else, here's a roundup of the regulatory actions you may have missed:
Parasol Therapeutics Moves to Neighborhood with $3.25M in Seed Funding---Hunting for Universal Therapeutic to Battle Drug-Resistant Flu
Parasol Therapeutics Moves to Neighborhood with $3.25M in Seed Funding—Hunting for Universal Therapeutic to Battle Drug-Resistant Flu Parasol Therapeutics, a stealthy biotech startup co-founded by MIT bioengineering professor Ram Sasisekharan, has raised $3.25 million in a seed round of venture capital to develop new treatments and diagnostics initially for influenza, says Alan Crane, a general partner at Polaris Venture Partners and chairman of Parasol.
Schmallenberg Virus - Causes, Symptoms & Prevention
Schmallenberg Virus – Causes, Symptoms & Prevention Schmallenberg Virus is a disease that affects cattle and sheep, which causes the birth of malformed calves and lambs. This disease was first identified as late as 2011 in Germany, so there is still much to learn about the disease. Symptoms of Schmallenberg Virus The symptoms of Schmallenberg Virus are abortion and stillbirth in ruminants and malformation of offspring.
Designing for the Digital Native: Generation Z
While marketers across all industries have focused heavily on attracting millennials, another generation of consumers is coming of age. The oldest members of this demographic are barely out of high school, but the traits and habits of Generation Z are already starting to drive business decisions. The hotel and lodging industry should take note: This is the next generation of guests to come through your lobby.
Molecular Insight Pharma, Xconomy's Neighbor, Faces Uncertain Future in Chapter 11
Molecular Insight Pharmaceuticals, which shares a floor with Xconomy in the building at 101 Rogers Street, is in financial trouble. The Cambridge, MA-based company, a developer of molecular medicines for cancer founded in 1997, has been in Chapter 11 since December 9. The company, which defaulted last year on a $150 million bond, has been unable to come to new terms with its bondholders.
Thomson Reuters and Linguamatics Release New Solution to Advance Pharma Clinical Trial R&D
PHILADELPHIA, Dec. 4, 2014 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, today announced a collaboration with Linguamatics to advance pharmaceutical clinical trial research and development (R&D) with the launch of CortellisTM Informatics Clinical Text Analytics for I2E.
Expert exposes 'highly questionable' data from biotech Cardio3 after IPO
Last week Cardio3 BioSciences wrapped up a €23 million ($29.6 million) IPO, a deal that Forbes contributor Larry Husten argues was based on inconsistent data that he called "highly questionable." He cites an expert who drilled into Phase II data from a study of the Belgian biotech's cellular therapy for heart failure, highlighting miscalculations and suspicious activity in the execution and reporting of the study.
Why pharma should care about FDA’s guidance on mobile apps
The FDA dished out final guidance Monday on regulation of mobile medical apps, shedding light on which apps are likely to require the U.S. agency's enforcement and which ones could be largely left alone. The guidance states that the majority of mobile apps are unlikely to require much regulatory scrutiny because they pose very little risk to patients.
UPDATED: San Diego biotech insider accused of shooting RNAi expert and brother-in-law
San Diego police say that biotech entrepreneur Hans Petersen shot and wounded his brother-in-law Ron Fletcher and the University of California, San Diego scientist Steven Dowdy at separate times and locations Thursday, The Associated Press reported. Authorities have arrested Petersen for attempted murder and other charges. Dowdy was shot in the lower back, the AP reported.
EU body endorses 11 new drugs from Glaxo, Roche, J&J and others
A European Union regulator has recommended approval of 11 new drugs for a range of diseases such as HIV, breast cancer and diabetes. And the nods could lead to final approvals from the European Commission in the coming months. Many of the drugs have already gained FDA approvals, yet the European Medicines Agency noted that the 11 recommendations for approval from its Committee for Medicinal Products for Human Use (CHMP) mark the most nods in a single meeting this year.
Next FierceBiotech Event: 'Big Data Gets Smart'
The term "Big Data" sounds mostly like marketing speak to real data scientists, who work with datasets of all sizes to develop applications in healthcare and other sectors. For these data pros, it's about having the right data, not just a lot of data, to make sure they are providing something of value to a customer.
Treato releases latest software: not another social media-listening app for pharma?
After landing venture bucks from marquee backers in April, Treato has rolled out a new version of its software for analyzing massive amounts of data from online patient posts and commentary. Treato CEO Ido Hadari has been trying to convince pharma companies that his startup's software offers advances from so-called "social media-listening" applications.
With NIH support, Eli Lilly follows NPS Pharma into hunt for rare disease therapy
Eli Lilly ($LLY) has found a new path into the hot rare-disease field. An NIH program has backed the Indianapolis-based drug giant's preclinical-stage research of a potential treatment for a hormone deficiency often caused by a genetic defect. Uncle Sam is teaming up with Lilly on development of a long-acting hormone replacement for the rare disease, known as hypoparathyroidism, which causes a lack of parathyroid hormone.
Gilead leaps ahead with FDA app for PI3K cancer killer
Gilead Sciences ($GILD) has sped ahead of rivals in the race to develop PI3K delta-targeted drugs for treating blood cancer, filing a new drug application with the FDA for its contender called idelalisib. As the biotech giant had said was a possibility, Gilead is seeking an early approval for idelalisib to combat indolent cases of non-Hodgkin's lymphoma (NHL) that fail to respond to rituximab and alkylating-agent chemotherapies.
Citivas scoops up $38M B round for inhaled Parkinson's drug
Civitas Therapeutics has scored fresh financing en route to potential late-stage development of an inhaled form of levodopa to treat symptoms of Parkinson's disease. Bay City Capital led the $38 million Series B round, which follows the start of a Phase IIb study for the startup's Parkinson's candidate CVT-301. Other first-time backers included RA Capital and another, undisclosed public investment group.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ryan
Contact Ryan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack